Colgate Q3 FY2026: sales up 4.6%, base EPS up 7.0%, guidance raised
Colgate posted a clean quarter: sales up 4.6% to $5.37 billion, base-business EPS up 7.0%, gross margin up 80 basis points, and management raised full-year margin and earnings guidance. The blemish is North America, where volume fell 3.7% and segment profit dropped 11.0%. Our view is Bullish, because cash generation and margin expansion are doing work that volume is not.
1 · Expected vs. Actual
Free preview belowGAAP EPS was $0.94, up 3.0%, while base-business EPS was $0.97, up 7.0%. Against the $0.9535 consensus, that is a slight miss on the GAAP number and a slight beat on the base-business number. The $0.03 per-share gap between the two is almost entirely Strategic Growth and Productivity Program charges.
Revenue of $5.37 billion rose 4.6% from $5.13 billion a year earlier, with organic sales up 3.6%. Latin America (+12.5% reported) and Hill's Pet Nutrition (+5.6%) carried the quarter, while North America fell 1.7%. No consensus revenue figure was supplied, so the sales line can only be judged against last year's base.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-02
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.